Development and validation of a normal-phase high-performance thin layer chromatographic method for the analysis of sulfamethoxazole and trimethoprim in co-trimoxazole tablets

Journal of Chromatography A

Volumn 1216, Issue 42, 2009, Pages 7102-7107

  Shewiyo, D H ^a,b,c   Kaale, E ^b   Risha, P G ^b   Dejaegher, B ^c   Smeyers Verbeke, J ^c   Vander Heyden, Y ^c  

^a Tanzania Food and Drugs Authority   (Tanzania)

^b MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^c PHARMACEUTICAL INSTITUTE   (Belgium)

Author keywords

Co trimoxazole tablets; Method development; Method validation; Normal phase HPTLC; Sulfamethoxazole (SMX); Trimethoprim (TMP)

Indexed keywords

CO-TRIMOXAZOLE TABLETS; METHOD DEVELOPMENT; METHOD VALIDATION; NORMAL-PHASE HPTLC; SULFAMETHOXAZOLE (SMX); TRIMETHOPRIM (TMP);

HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LAWS AND LEGISLATION; METHANOL; QUALITY ASSURANCE; QUALITY FUNCTION DEPLOYMENT; SILICA; SILICA GEL; THERMOMECHANICAL PULPING PROCESS; THIN FILMS; TOLUENE; TOTAL QUALITY MANAGEMENT;

QUALITY CONTROL;

ACETIC ACID ETHYL ESTER; COTRIMOXAZOLE; METHANOL; SULFAMETHOXAZOLE; TOLUENE; TRIMETHOPRIM;

ACCURACY; ARTICLE; CALIBRATION; CONTROLLED STUDY; DENSITOMETRY; DRUG IDENTIFICATION; DRUG STRUCTURE; HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PRODUCT RECOVERY; QUALITY CONTROL; REPRODUCIBILITY; SEPARATION TECHNIQUE; TABLET; VALIDATION PROCESS;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, THIN LAYER; LINEAR MODELS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SULFAMETHOXAZOLE; TABLETS; TRIMETHOPRIM; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

PNEUMOCYSTIS CARINII;

EID: 70349206029     PISSN: 00219673     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chroma.2009.08.076     Document Type: Article

References (25)

1. Johnson T., Khan I.A., Avery M.A., Grant J., and Meshnick S.R. Antimicrob. Agents Chemother. 42 (1998) 1454
2. Guidelines on Co-trimoxazole prophylaxis for HIV-related infections among children, adolescents and adults in resource limited settings, Recommendations for a public health approach, HIV/AIDS programme, WHO, Geneva, 2006.
3. B.T. Mmbaga, G. Kinabo, M. Swai, J. F. Shao, J. Mchele, M. Henderikx, B. Mulder, E. Houpt, J. Tolboom, W. Schimana, Positive effects of Co-trimoxazole prophylaxis in HIV Infected children in Kilimanjaro Tanzania, a poster presentation available at (http://www.retroconference.org/2007/PDFs/705.pdf), accessed on 5th February 2009.
4. Risha P.G., Msuya Z., Clark M., Johnson K., Sigonda M.N., and Layloff T. Health Policy 87 (2008) 217
5. The United States Pharmacopoeia 24, National Formulary 19, United States Pharmacopoeia Convention, Rockville MD, USA, 1995.
6. Kulikov A.U., Verushkin A.G., and Loginova L.P. Chromatographia 61 (2005) 455
7. Amini H., and Ahmadiani A. J. Pharm. Biomed. Anal. 43 (2007) 1146
8. Épshtein N.A. Pharm. Chem. J. 36 (2002) 675
9. Pereira A.V., and Cass Q.B. J. Chromatogr. B. 826 (2005) 139
10. Gochin R., Kunfer I., and Haigh J.M. J. Chromatogr. 223 (1981) 139
11. Chair M., Nelis H.J., Leger P., Sorgeloos P., and De Leenheer A.P. Antimicrob. Agents Chemother. 40 (1996) 1649
12. Chakwenya J., Lakrittz J., Tyler J., Fales W.H., James-Kracke M., Smith K., and Holle J. J. Vet. Pharmacol. Ther. 25 (2002) 321
13. Haller M.Y., Muller S.R., McArdell C.S., Alder A.C., and Suter M.J.F. J. Chromatogr. A 952 (2002) 111
14. Balyejjusaa S., Adomeband R.O., and Musok D. Afr. Health Sci. 2 (2002) 56
15. Berzas Nevado J.J., Lemus Gallego J.M., and Castafieda Pefialvo G. J. Anal. Chem. 342 (1992) 723
16. Dhasan P.B., Tripathi M., Sundaram R., Venkataranganna M.V., Gopumadhavan S., and Kulkarni K.S. Indian Drugs 38 (2001) 526
17. Ali J., Ali N., Sultana Y., Baboota S., and Faiyaz S. Acta Chromatogr. 18 (2007) 168
18. Kalasz H., and Bathori M. In: Valko K. (Ed). Handbook of Analytical Separations 1 (2000), Elsevier, Amsterdam 439
19. Guidelines prepared within the International Conference on Harmonization of Technical Requirements for the Registration of Pharmaceuticals for Human use (ICH), Validation of Analytical Procedures: Text and Methodology, Q2(R1). http://www.ich.org/, 2005, 1-13 (accessed on January 26th 2009).
20. Funk W., Dammann V., and Donnevert G. Quality Assurance in Analytical Chemistry. second ed. (2007), Wiley-VCH, Weinhein
21. R.W.O. Jahnke, A concise Quality Control Guide on Essential Drugs; Volume II Thin layer Chromatography, in: Global Pharma Health Fund, (GPHF) Franfurt, Germany, 2001.
22. Touchstone J.C. Practice of Thin Layer Chromatography. third ed. (1992), John Wiley & Sons, New York
23. Box G.E.P., Hunter W.G., and Hunter J.S. An Introduction to Design, Data Analysis and Model Building (1978), J. Wiley, New York
24. Massart D.L., Vandeginste B.G.M., Buydens L.M.C., De Jong S., Lewi P.J., and Smeyers-Verbeke J. Handbook of Chemometrics and Qualimetrics: Part A (1997), Elsevier, Amsterdam pp. 121, 189
25. Vander Heyden Y., Nijhuis A., Smeyers-Verbeke J., Vandeginste B.G.M., and Massart D.L. J. Pharm. Biomed. Anal. 24 (2001) 723